Avalo Therapeutics, Inc.
NASDAQ:AVTX
8.81 (USD) • At close December 24, 2024
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | ||||||||||||
| Current Assets: | ||||||||||||
| Cash & Cash Equivalents
| 7.415 | 13.172 | 54.585 | 18.919 | 3.609 | 10.646 | 2.472 | 5.128 | 21.162 | 11.742 | 3.421 | 9.52 |
| Short Term Investments
| 0 | 0 | 0 | 0 | 7.629 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 7.415 | 13.172 | 54.585 | 18.919 | 11.238 | 10.646 | 2.472 | 5.128 | 21.162 | 11.742 | 3.421 | 9.52 |
| Net Receivables
| 0.136 | 1.919 | 4.799 | 2.177 | 0 | 0.822 | 2.935 | 0.132 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0.02 | 0.038 | 0.003 | 0.021 | 1.111 | 0.382 | 0.011 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 0.844 | 1.305 | 2.423 | 4.906 | 1.912 | 10.145 | 4.885 | 0.402 | 0.46 | 0.419 | 0.714 | 0.43 |
| Total Current Assets
| 8.395 | 16.416 | 61.845 | 26.005 | 17.724 | 21.932 | 10.991 | 5.663 | 21.623 | 12.161 | 4.136 | 9.95 |
| Non-Current Assets: | ||||||||||||
| Property, Plant & Equipment, Net
| 1.965 | 2.411 | 2.695 | 1.607 | 1.448 | 0.587 | 0.045 | 0.043 | 0.035 | 0.039 | 0.066 | 0.057 |
| Goodwill
| 10.502 | 14.409 | 14.409 | 14.409 | 14.409 | 16.411 | 14.292 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0.038 | 1.585 | 2.426 | 31.239 | 17.664 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 10.502 | 14.409 | 14.447 | 15.994 | 16.835 | 47.651 | 31.957 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0.131 | 0.227 | 0.149 | 0.102 | 0.082 | 0.131 | 0.063 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | -0.131 | -0.227 | -0.149 | -0.102 | 0.091 | -0.131 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.131 | 0.131 | 1.227 | 0.149 | 0.102 | -0.091 | 0.131 | 0 | 0 | 0.117 | 0.874 | -0.057 |
| Total Non-Current Assets
| 12.598 | 16.951 | 18.369 | 17.75 | 18.385 | 48.319 | 32.133 | 0.106 | 0.035 | 0.156 | 0.94 | 0.057 |
| Total Assets
| 20.993 | 33.367 | 80.214 | 43.755 | 36.109 | 70.251 | 43.124 | 5.769 | 21.658 | 12.317 | 5.076 | 10.02 |
| Liabilities & Equity: | ||||||||||||
| Current Liabilities: | ||||||||||||
| Account Payables
| 0.446 | 2.882 | 3.369 | 2.574 | 2.078 | 1.446 | 1.299 | 1.01 | 0.678 | 0.931 | 1.64 | 0.821 |
| Short Term Debt
| 0.537 | 6.462 | 0.485 | 0.426 | 0.156 | 0 | 0 | 2.354 | 3.208 | 1.906 | 0 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0.552 | 2.032 | 2.259 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0.088 | 16.025 | 10.884 | -0.156 | 2.032 | 0 | 0.943 | 1.885 | 0.975 | 0 | 0 |
| Other Current Liabilities
| 3.635 | 12.682 | 16.034 | 12.225 | 9.375 | 22.738 | 7.848 | 0.948 | 1.964 | 2.157 | 1.426 | 0.723 |
| Total Current Liabilities
| 4.618 | 22.114 | 19.888 | 15.225 | 12.161 | 26.217 | 11.406 | 4.312 | 5.85 | 4.994 | 3.066 | 1.544 |
| Non-Current Liabilities: | ||||||||||||
| Long Term Debt
| 0 | 13.486 | 32.833 | 0 | 1.112 | 0 | 0 | 0 | 2.353 | 5.308 | 0 | 0 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | -2 | -1.112 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0.155 | 0.141 | 0.113 | 0.09 | 0.086 | 0.069 | 0.007 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 8.916 | 8.541 | 4.298 | 3.968 | 1.755 | 23.057 | 3.851 | 1.25 | 0.371 | 28.346 | 19.857 | 0 |
| Total Non-Current Liabilities
| 9.071 | 22.168 | 37.244 | 3.968 | 2.953 | 23.126 | 3.858 | 1.25 | 8.574 | 33.654 | 19.857 | 0 |
| Total Liabilities
| 13.689 | 44.282 | 57.132 | 19.193 | 15.114 | 49.343 | 15.264 | 5.562 | 8.574 | 38.648 | 22.922 | 1.544 |
| Equity: | ||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0.001 | 0.003 | 0.003 | 0 | 0 | 21,657.565 | 28.346 | 19.857 | 19.857 |
| Common Stock
| 0.001 | 0.009 | 0.113 | 0.075 | 0.044 | 0.041 | 2.687 | 0.009 | 0.009 | 0.001 | 0.001 | 0.018 |
| Retained Earnings
| -335.134 | -303.824 | -262.166 | -177.79 | -114.291 | -98.218 | -58.165 | -70.035 | -53.563 | -43.073 | -27.018 | -13.973 |
| Accumulated Other Comprehensive Income/Loss
| 0 | 0 | 0 | -0 | -0 | 0 | 2.655 | 0 | -21,657.565 | -28.346 | -19.857 | 0 |
| Other Total Stockholders Equity
| 342.437 | 292.9 | 285.135 | 202.276 | 135.239 | 119.082 | 83.338 | 70.233 | 66.639 | 16.742 | 9.17 | 2.574 |
| Total Shareholders Equity
| 7.304 | -10.915 | 23.082 | 24.562 | 20.995 | 20.908 | 27.86 | 0.207 | 13.084 | -26.331 | -17.847 | 8.476 |
| Total Equity
| 7.304 | -10.915 | 23.082 | 24.562 | 20.995 | 20.908 | 27.86 | 0.207 | 13.084 | -26.331 | -17.847 | 8.476 |
| Total Liabilities & Shareholders Equity
| 20.993 | 33.367 | 80.214 | 43.755 | 36.109 | 70.251 | 43.124 | 5.769 | 21.658 | 12.317 | 5.076 | 0 |